Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review.
about
Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.Amitriptyline for neuropathic pain in adultsAlpha-lipoic acid for diabetic peripheral neuropathyAmitriptyline for neuropathic pain and fibromyalgia in adultsValproic acid and sodium valproate for neuropathic pain and fibromyalgia in adultsAntidepressants for neuropathic painAlpha-lipoic acid for diabetic peripheral neuropathyAntidepressants for neuropathic painControlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10Epidemiology of Fractures in Diabetes.Discovery of diphenyl amine based sodium channel blockers, effective against hNav1.2.Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005.Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.Diabetic neuropathy: mechanisms to managementThe management of diabetic neuropathy in CKD.Pharmacologic management of chronic pain.Gabapentin: pharmacology and its use in pain management.Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia.WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression.Olanzapine: another psychotropic?Neuropathic pain: evidence matters.Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.Current aproach to cancer pain management: Availability and implications of different treatment options.Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitineThe pathogenesis and management of painful diabetic neuropathy: a review.Gynecologic management of neuropathic pain.Opioids for managing chronic non-malignant pain: safe and effective prescribing.Systematic overview of the pharmacological management of postherpetic neuralgia. An evaluation of the clinical value of critically selected drug treatments based on efficacy and safety outcomes from randomized controlled studies.Treatment of chronic pain in persons with dementia: an overview.Emerging therapies for neuropathic pain.Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder.Palladium-catalyzed α-arylation of aryl acetic acid derivatives via dienolate intermediates with aryl chlorides and bromides.Practical management of patients with painful diabetic neuropathy.The pharmacotherapy of chronic pain: a review.Exacerbated mechanical allodynia in rats with depression-like behavior.Pregabalin for pain management.Viral vector-based gene transfer for treatment of chronic pain.Role of neuroimaging in analgesic drug development.A comparative study of efficacy and safety of gabapentin versus amitriptyline as coanalgesics in patients receiving opioid analgesics for neuropathic pain in malignancy.Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain?
P2860
Q21144723-CF3A8F42-6A98-4A44-917F-9A4B3D0EA6E1Q24186538-A33127AC-1A9A-478C-835C-62922511F9F8Q24187870-140AF032-384B-48F7-90DB-B507BCBB1173Q24202439-87F4CDF4-BD19-45B0-8592-670D88E9B279Q24235890-BBEF1610-DB6E-4966-8268-ECD508051F34Q24243292-3E67D669-EF83-4C65-B24E-278D4395F15EQ24246065-22A1DF6E-4EA5-4495-BCD8-EC32B8FF4886Q24246575-2D70985D-97F3-42AB-8621-2A43538DA0C8Q24796221-BC665324-3C96-41F0-B956-19EAE47CC74BQ30248863-FA25B3E2-B53F-427F-BE40-FB18BCF0EFB2Q30438242-8E8382BB-EC87-435C-8158-E531726086D8Q33332025-A1901BBB-069F-4169-A7A9-CCA6EB9BBA75Q33408025-E7F87897-AB45-4C15-A8C1-4D9C855F50DCQ33554384-DDCF86F4-DC58-4A8A-BC30-9C3AA3FB8D38Q33554396-7706E973-FD22-4118-A43D-2A2AC5E23D67Q33915700-5B5D74B0-612B-4009-8482-A1AEAB610B57Q33958706-4819939A-CAA0-4AD4-A5BA-72FD5B635AE7Q34074987-97067B06-20BD-4278-BF9A-596E52C28BAFQ34112969-7948E59E-871D-4AD2-A9FC-AE3215F84212Q34283153-DD11A530-BA92-45A5-B308-09B90EF6BB4DQ34558516-0AA29DD1-E086-456D-9004-73F32EF1488CQ34608780-766D188C-09D2-4260-8D39-81B49520E83BQ34779398-173FAF45-04D1-4B80-BCE1-E0622A387B40Q34997110-DD376FD6-1236-4F2F-8D46-59DCA032E3FAQ35064423-B6A6FA39-BC36-416A-910F-EE527C870A62Q35489433-20719C34-A1E0-4C83-B0A7-F49F56B6FEC5Q35613260-952BC6F3-ECFC-4294-AB27-3BCF197D6D53Q35760514-222C1C86-272B-4FD1-B6E6-B6E6EE1847F9Q36063652-5D93B90F-24A8-489C-8A58-A16F6FA910ECQ36066028-756CADEE-EAA5-47BF-A19C-53366D7FAE7AQ36103337-D9ABD7A1-0482-4238-AAB9-EA5B57019DAEQ36175602-C2522868-42AD-4B35-961C-2CDD07C653EBQ36229369-12DE4290-8EC5-4075-9FA9-3CF618770846Q36411163-0633F629-080A-4D0B-AEA5-B2BCD623982BQ36662841-B101D0CE-1BCB-459D-8A31-12870738C0BFQ36687433-BA7AFEB6-4543-46B0-8BFC-294D965317E3Q36787828-648D70FA-7267-499C-B826-F462C008E3B3Q37036818-E8171EB1-F2EE-4A5B-9D92-7F3CA62B7C99Q37133290-86B4FCB5-04BA-4A07-BB3A-0E39EE3D6248Q37154511-7392609B-EE85-4101-A78F-9D0156874E5D
P2860
Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Antidepressants and anticonvul ...... uantitative systematic review.
@ast
Antidepressants and anticonvul ...... uantitative systematic review.
@en
type
label
Antidepressants and anticonvul ...... uantitative systematic review.
@ast
Antidepressants and anticonvul ...... uantitative systematic review.
@en
prefLabel
Antidepressants and anticonvul ...... uantitative systematic review.
@ast
Antidepressants and anticonvul ...... uantitative systematic review.
@en
P2093
P1476
Antidepressants and anticonvul ...... uantitative systematic review.
@en
P2093
P304
P356
10.1016/S0885-3924(00)00218-9
P577
2000-12-01T00:00:00Z